SUPERCON – sprøytebetong kan redusere tunnelers klimafotavtrykk

I forskningsprosjektet SUPERCON utvikler vi teknologi for vanntett sprøytebetong. Ved å benytte denne teknologien som alternativ til tradisjonell tunnelkledning for vannsikring av norske tunneler, kan bransjen redusere klimafotavtrykket betraktelig.publishedVersio

Experimental Study of Acid Fracture Conductivity of Austin Chalk Formation

Acid fracture conductivity and the effect of key variables in the etching process during acid fracturing can be assessed at the laboratory scale. This is accomplished by using an experimental apparatus that simulates acid injection fluxes comparable to those in actual acid fracture treatments. After acid etching, fracture conductivity is measured at different closure stresses. This research work presents a systematic study to investigate the effect of temperature, rock-acid contact time and initial condition of the fracture surfaces on acid fracture conductivity in the Austin Chalk formation. While temperature and rock-acid contact are variables normally studied in fracture conductivity tests, the effect of the initial condition of the fracture surface has not been extensively investigated. The experimental results showed that there is no significant difference in acid fracture conductivity at high closure stress using smooth or rough fracture surfaces. In addition, we analyzed the mechanisms of acid etching and resulting conductivity creation in the two types of fracture surfaces studied by using surface profiles. For smooth surfaces, the mechanism of conductivity creation seems connected to uneven etching of the rock and roughness generation. For rough surfaces, acid conductivity is related to smoothing and deepening of the initial features on the sample surface than by creating more roughness. Finally, we compared the experimental results with Nirode-Kruk correlation for acid fracture conductivity

Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide

The major potential adverse effect of use of sulfonylurea agents (SUAs) is a hyperinsulinaemic state that causes hypoglycaemia. It may be observed during chronic therapeutic dosing, even with very low doses of a SUA, and especially in older patients. It may also result from accidental or intentional poisoning in both diabetic and nondiabetic patients. The traditional approach to SUA-induced hypoglycaemia includes administration of glucose, and glucagon or diazoxide in those who remain hypoglycaemic despite repeated or continuous glucose supplementation. However, these antidotal approaches are associated with several shortcomings, including further exacerbation of insulin release by glucose and glucagon, leading only to a temporary beneficial effect and later relapse into hypoglycaemia, as well as the adverse effects of both glucagon and diazoxide. Octreotide inhibits the secretion of several neuropeptides, including insulin, and has successfully been used to control life-threatening hypoglycaemia caused by insulinoma or persistent hyperinsulinaemic hypoglycaemia of infancy. Therefore, this agent should in theory also be useful to decrease glucose requirements and the number of hypoglycaemic episodes in patients with SUA-induced hypoglycaemia. This has apparently been confirmed by experimental data, one retrospective study based on chart review, and several anecdotal case reports. There is thus a need for further prospective studies, which should be adequately powered, randomized and controlled, to confirm the probable beneficial effect of octreotide in this setting

Science review: Carnitine in the treatment of valproic acid-induced toxicity – what is the evidence?

Valproic acid (VPA) is a broad-spectrum antiepileptic drug and is usually well tolerated, but rare serious complications may occur in some patients receiving VPA chronically, including haemorrhagic pancreatitis, bone marrow suppression, VPA-induced hepatotoxicity (VHT) and VPA-induced hyperammonaemic encephalopathy (VHE). Some data suggest that VHT and VHE may be promoted by carnitine deficiency. Acute VPA intoxication also occurs as a consequence of intentional or accidental overdose and its incidence is increasing, because of use of VPA in psychiatric disorders. Although it usually results in mild central nervous system depression, serious toxicity and even fatal cases have been reported. Several studies or isolated clinical observations have suggested the potential value of oral L-carnitine in reversing carnitine deficiency or preventing its development as well as some adverse effects due to VPA. Carnitine supplementation during VPA therapy in high-risk patients is now recommended by some scientific committees and textbooks, especially paediatricians. L-carnitine therapy could also be valuable in those patients who develop VHT or VHE. A few isolated observations also suggest that L-carnitine may be useful in patients with coma or in preventing hepatic dysfunction after acute VPA overdose. However, these issues deserve further investigation in controlled, randomized and probably multicentre trials to evaluate the clinical value and the appropriate dosage of L-carnitine in each of these conditions

Bruk av sensorer kan halvere herdetiden for plasstøpte betongkonstruksjoner

publishedVersio

Breaks and Code Quality: Investigating the Impact of Forgetting on Software Development. A Registered Report

Developers interrupting their participation in a project might slowly forget critical information about the code, such as its intended purpose, structure, the impact of external dependencies, and the approach used for implementation. Forgetting the implementation details can have detrimental effects on software maintenance, comprehension, knowledge sharing, and developer productivity, resulting in bugs, and other issues that can negatively influence the software development process. Therefore, it is crucial to ensure that developers have a clear understanding of the codebase and can work efficiently and effectively even after long interruptions. This registered report proposes an empirical study aimed at investigating the impact of the developer's activity breaks duration and different code quality properties. In particular, we aim at understanding if the amount of activity in a project impact the code quality, and if developers with different activity profiles show different impacts on code quality. The results might be useful to understand if it is beneficial to promote the practice of developing multiple projects in parallel, or if it is more beneficial to reduce the number of projects each developer contributes

On the Empirical Evidence of Microservice Logical Coupling. A Registered Report

[Context] Coupling is a widely discussed metric by software engineers while developing complex software systems, often referred to as a crucial factor and symptom of a poor or good design. Nevertheless, measuring the logical coupling among microservices and analyzing the interactions between services is non-trivial because it demands runtime information in the form of log files, which are not always accessible. [Objective and Method] In this work, we propose the design of a study aimed at empirically validating the Microservice Logical Coupling (MLC) metric presented in our previous study. In particular, we plan to empirically study Open Source Systems (OSS) built using a microservice architecture. [Results] The result of this work aims at corroborating the effectiveness and validity of the MLC metric. Thus, we will gather empirical evidence and develop a methodology to analyze and support the claims regarding the MLC metric. Furthermore, we establish its usefulness in evaluating and understanding the logical coupling among microservices

Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study.

BACKGROUND: The PAST-BP trial found that using a lower systolic blood pressure target (<130 mmHg or lower versus <140 mmHg) in a primary care population with prevalent cerebrovascular disease was associated with a small additional reduction in blood pressure (2.9 mmHg). OBJECTIVES: To determine the cost effectiveness of an intensive systolic blood pressure target (<130 mmHg or lower) compared with a standard target (<140 mmHg) in people with a history of stroke or transient ischaemic attack on general practice stroke/transient ischaemic attack registers in England. METHODS: A Markov model with a one-year time cycle and a 30-year time horizon was used to estimate the cost per quality-adjusted life year of an intensive target versus a standard target. Individual patient level data were used from the PAST-BP trial with regard to change in blood pressure and numbers of primary care consultations over a 12-month period. Published sources were used to estimate life expectancy and risks of cardiovascular events and their associated costs and utilities. RESULTS: In the base-case results, aiming for an intensive blood pressure target was dominant, with the incremental lifetime costs being £169 lower per patient than for the standard blood pressure target with a 0.08 quality-adjusted life year gain. This was robust to sensitivity analyses, unless intensive blood pressure lowering reduced quality of life by 2% or more. CONCLUSION: Aiming for a systolic blood pressure target of <130 mmHg or lower is cost effective in people who have had a stroke/transient ischaemic attack in the community, but it is difficult to separate out the impact of the lower target from the impact of more active management of blood pressure.National Institute for Health Research (Grant ID: RP-PG-0606-1153)This is the author accepted manuscript. The final version is available from SAGE Publications via http://dx.doi.org/10.1177/204748731665198

Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack:economic analysis of the PAST-BP (Prevention After Stroke – Blood Pressure) Study

The PAST-BP trial found that using a lower systolic blood pressure target (<130 mmHg or lower versus <140 mmHg) in a primary care population with prevalent cerebrovascular disease was associated with a small additional reduction in blood pressure (2.9 mmHg).To determine the cost effectiveness of an intensive systolic blood pressure target (<130 mmHg or lower) compared with a standard target (<140 mmHg) in people with a history of stroke or transient ischaemic attack on general practice stroke/transient ischaemic attack registers in England.A Markov model with a one-year time cycle and a 30-year time horizon was used to estimate the cost per quality-adjusted life year of an intensive target versus a standard target. Individual patient level data were used from the PAST-BP trial with regard to change in blood pressure and numbers of primary care consultations over a 12-month period. Published sources were used to estimate life expectancy and risks of cardiovascular events and their associated costs and utilities.In the base-case results, aiming for an intensive blood pressure target was dominant, with the incremental lifetime costs being £169 lower per patient than for the standard blood pressure target with a 0.08 quality-adjusted life year gain. This was robust to sensitivity analyses, unless intensive blood pressure lowering reduced quality of life by 2% or more.Aiming for a systolic blood pressure target of <130 mmHg or lower is cost effective in people who have had a stroke/transient ischaemic attack in the community, but it is difficult to separate out the impact of the lower target from the impact of more active management of blood pressure

Pre-hospital management protocols and perceived difficulty in diagnosing acute heart failure

Aim To illustrate the pre-hospital management arsenals and protocols in different EMS units, and to estimate the perceived difficulty of diagnosing suspected acute heart failure (AHF) compared with other common pre-hospital conditions. Methods and results A multinational survey included 104 emergency medical service (EMS) regions from 18 countries. Diagnostic and therapeutic arsenals related to AHF management were reported for each type of EMS unit. The prevalence and contents of management protocols for common medical conditions treated pre-hospitally was collected. The perceived difficulty of diagnosing AHF and other medical conditions by emergency medical dispatchers and EMS personnel was interrogated. Ultrasound devices and point-of-care testing were available in advanced life support and helicopter EMS units in fewer than 25% of EMS regions. AHF protocols were present in 80.8% of regions. Protocols for ST-elevation myocardial infarction, chest pain, and dyspnoea were present in 95.2, 80.8, and 76.0% of EMS regions, respectively. Protocolized diagnostic actions for AHF management included 12-lead electrocardiogram (92.1% of regions), ultrasound examination (16.0%), and point-of-care testings for troponin and BNP (6.0 and 3.5%). Therapeutic actions included supplementary oxygen (93.2%), non-invasive ventilation (80.7%), intravenous furosemide, opiates, nitroglycerine (69.0, 68.6, and 57.0%), and intubation 71.5%. Diagnosing suspected AHF was considered easy to moderate by EMS personnel and moderate to difficult by emergency medical dispatchers (without significant differences between de novo and decompensated heart failure). In both settings, diagnosis of suspected AHF was considered easier than pulmonary embolism and more difficult than ST-elevation myocardial infarction, asthma, and stroke. Conclusions The prevalence of AHF protocols is rather high but the contents seem to vary. Difficulty of diagnosing suspected AHF seems to be moderate compared with other pre-hospital conditions